|Bid||0.00 x 800|
|Ask||0.00 x 3100|
|Day's Range||9.57 - 9.72|
|52 Week Range||8.54 - 14.97|
|Beta (3Y Monthly)||1.54|
|PE Ratio (TTM)||4.65|
|Earnings Date||May 2, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.22|
AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Electronic health records company Allscripts Healthcare Solutions Inc. (MDRX) is a leader in healthcare information tech, observes David Fried, an industry-lead expert in corporate repurchase programs and editor of The Buyback Letter.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for th...
Allscripts Healthcare Solutions Inc NASDAQ/NGS:MDRXView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate Bearish sentimentShort interest | NeutralShort interest is moderate for MDRX with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding MDRX are favorable with net inflows of $72.35 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
CHICAGO, March 27, 2019 -- Allscripts (NASDAQ: MDRX) has been recognized by Frost & Sullivan with the 2019 Best Practices Award for its population health management.
Allscripts' (MDRX) FollowMyHealth is an EHR-neutral patient engagement platform that allows patients to stay connected with their physicians.
“Innovative providers across the United States are realizing that FollowMyHealth offers the most comprehensive and integrated enterprise and mobile patient engagement platform on the market,” said Allscripts, Senior Vice President Raj Toleti.
AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pulse8, part of Veradigm™, an Allscripts (MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, is excited to become the latest collaborating partner within the Health Plan Alliance Group Purchasing Organization (GPO). Pulse8 will be offering its Formul8 product, along with unique and valuable analytic insight, to members of the Alliance.
Allscripts' (MDRX) partnership with Opargo is likely to improve scheduling capabilities and practice workflows of Allscripts Practice Management solution.
Pulse8, part of Veradigm™, an Allscripts (MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, proudly debuted several significant enhancements to its illumin8 Solution Suite this quarter – most notably, the advent of an ACO-specific module to their flagship risk adjustment solution as well as the implementation of Pulse Alerts across its customer base of innovative health plans and at-risk providers. Pulse Alerts are yet another embodiment of the advanced illumin8 Active Intelligence platform that Pulse8 announced at last year’s RISE Nashville Summit. Now implemented at various health plans across the country, Pulse Alerts radically transform data analysis from a reactive and laborious data mining exercise to a proactive and insightful process.
Today, Allscripts (MDRX) announced a strategic partnership with Opargo focused on delivering integrated technology to improve health care efficiency and reduce schedule churn through real-time schedule optimization. Allscripts has long held and invested in the fact that health care is in critical need to enhance patient care scheduling, improve patient access and increase efficiency of clinic and health system operations. The Opargo partnership accelerates this goal in a way that is expected to add significant value for Allscripts customers. Opargo is a SaaS solution that uses predictive analytics and the proven optimization principles of the airline and hotel industries to improve practice efficiencies at time of scheduling. Opargo’s founders are a former airline technology executive and a practicing physician with the mission to use data and analytics to ensure physicians are the “Right Kind of Busy”.
Pulse8 is likely to boost Allscripts' (MDRX) flagship platform Veradigm, and its existing health plan product suite that delivers pocket-friendly tools and services for health plan members.
Qatar-based Alfardan Group and Chicago-based Northwestern Medicine select Allscripts (MDRX) for the launch of a project in the Middle East.
Veradigm™, an Allscripts (MDRX), business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and technology company. Pulse8 is the first, and only with a patent pending, healthcare analytics and technology company delivering a complete enterprise platform to provide visibility into the efficacy of Risk Adjustment, Quality Improvement, and Pharmacy Management programs. Pulse8 enables both health plans and at-risk providers to achieve precise risk and quality scores in the Medicare Advantage, Managed Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. Pulse8’s Illumin8™ Active Intelligence™ platform offers a suite of uniquely pragmatic solutions that are powered by patent-pending Dynamic Intervention Planning to deliver cost-effective and appropriate interventions for closing gaps in documentation, coding, and quality.
Allscripts (MDRX) announced today that Alfardan Group, one of the leading family-owned conglomerates in Qatar, and Chicago-based Northwestern Medicine have selected Allscripts to provide ambulatory care services for the launch of its new project, Alfardan Medical with Northwestern Medicine. The project is a part of Allscripts expansion in the Middle East and will provide ambulatory care services including Sunrise™ Ambulatory, Sunrise™ Surgery, Sunrise™ Radiology, Allscripts® Clinical Performance Management, Allscripts Lab™ and iPro Anesthesia™.
Paul Black has been the CEO of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) since 2012. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companiesRead More...
Arise Austin Medical Center, located in Austin, TX and The Hospital at Westlake Medical Center, located in West Lake Hills, TX have announced that both organizations will deploy Allscripts (MDRX) Sunrise platform as its new core clinical and financial system to help coordinate the care, treatment and health of the Austin community it serves. Arise Austin Medical Center is a licensed general acute care hospital that provides a full spectrum of general, surgical and specialized care.
NEW YORK, March 05, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Allscripts (MDRX) announced today that Saint Anthony Hospital has signed a Paragon expansion, confirming its commitment to improving the quality of patient care by creating a single unified EMR across its hospital and clinics. Saint Anthony Hospital, located in Chicago, IL, is an independent, nonprofit, acute care, community hospital dedicated to improving the health and wellness of the families on the West Side and Southwest Side of Chicago. The hospital provides medical care, social services, and community outreach to the residents of surrounding neighborhoods.
Blessing Health System, a not-for-profit healthcare organization based in Quincy, Ill., expanded and extended its commitment to Allscripts (MDRX), creating one single integrated clinical and financial patient record. Blessing Health System has provided care for Quincy and its surrounding community since 1875. The organization is a multi-facility system that includes Blessing Hospital, Illini Community Hospital, Hannibal Clinic, Blessing Physician Services, Blessing-Rieman College of Nursing, The Blessing Foundation, and Denman Services, Inc.